Trial Profile
Extension, Open-label, Interventional, Long-term Study to Evaluate the Safety of Tocilizumab Treatment in Patients From Brazil With Polyarticular-course Juvenile Idiopathic Arthritis Who Completed the Global Multinational Trial (WA19977)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Mar 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Roche
- 31 Dec 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 11 May 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Sep 2015 to 1 Sep 2017.
- 11 May 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Sep 2015 to 1 Sep 2017.